PRECISION NEO-STIM
Dead / Abandoned — Abandoned — failure to respond (as of 09 Jun 2023)
What this means for you
This application is over — abandoned 13 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88984596
- Mark type
- Stylized text
- Filed
- 16 Apr 2020
- Published for opposition
- 23 Feb 2021
- Abandoned
- 13 Apr 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; consulting services for others in the field of design, planning, and implementation of clinical trials
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical consultation; providing information relating to therapeutic properties of pharmaceuticals
Owner
- BIONTECH US INC., Cambridge, MA, US
- BIONTECH US INC., DOVER, DE, US
- Neon Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 09 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 09 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — SU - NON-FINAL ACTION - WRITTEN
- 31 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Aug 2022 — USE AMENDMENT FILED
- 31 Aug 2022 — DIVISIONAL PROCESSING COMPLETE
- 11 Aug 2022 — DIVISIONAL REQUEST RECEIVED
- 31 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Aug 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 27 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2022 — SOU EXTENSION 2 GRANTED